Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real‐time PCR
Gunter Kerst(University Children's Hospital Tübingen), Peter Bader(Goethe University Frankfurt), Ingo Müller(Universität Hamburg), Elaine Coustan‐Smith(St. Jude Children's Research Hospital), C Well(St. Jude Children's Research Hospital), Dario Campana(National University of Singapore), Klaus Dietz(University of Tübingen), Ewa Kościelniak(University of Tübingen), Charlotte M. Niemeyer(University of Freiburg), Paul G. Schlegel(Goethe University Frankfurt), Carmen Roth(St. Jude Children's Research Hospital), D. Niethammer(University Children's Hospital Tübingen), Hermann Kreyenberg(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 122
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k